MedservRegis Plc — Capital/Financing Update 2022

Nov 10, 2022

COMPANY ANNOUNCEMENT MEDSERVREGIS P.L.C. (THE "COMPANY")

Regulatory Approval of Prospectus

Date of Announcement	10 November 2022
Reference	277/2022
Listing Rule	CMR 5.16

Quote

The Company refers to the announcement issued on 2 November 2022 (275/2022) where it was announced that the Company had filed an application with the Malta Financial Services Authority requesting admissibility to listing on the Official List of the Malta Stock Exchange of a maximum of €13,000,000 secured bonds redeemable in 2029 (the New Bonds), to be issued at par.

The Company hereby announces that it has received regulatory approval for the issue of the New Bonds. Full details thereof are set out in the Prospectus dated 9 November 2022, a copy of which is available on the Company's website (www.medservregis.com). Copies of the prospectus may be obtained from Authorised Financial Intermediaries specified in Annex 3 of the Securities Note (forming part of the Prospectus) as from the 21 November 2022.

Application forms will be mailed to Callable Bondholders (being holders of the originally issued €20 million 6% MedservRegis p.l.c. Secured Bonds 2023) on or around 14 November 2022.

The New Bonds shall bear interest at the rate of 5% payable annually in arrears.

Unquote

Laragh Cassar Company Secretary